These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 19158152)
21. Levosimendan versus dobutamine in critically ill patients: a meta-analysis of randomized controlled trials. Huang X; Lei S; Zhu MF; Jiang RL; Huang LQ; Xia GL; Zhi YH J Zhejiang Univ Sci B; 2013 May; 14(5):400-15. PubMed ID: 23645177 [TBL] [Abstract][Full Text] [Related]
22. Comparative effects of levosimendan and dobutamine on right ventricular function in patients with biventricular heart failure. Yilmaz MB; Yontar C; Erdem A; Karadas F; Yalta K; Turgut OO; Yilmaz A; Tandogan I Heart Vessels; 2009 Jan; 24(1):16-21. PubMed ID: 19165563 [TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Follath F; Cleland JG; Just H; Papp JG; Scholz H; Peuhkurinen K; Harjola VP; Mitrovic V; Abdalla M; Sandell EP; Lehtonen L; Lancet; 2002 Jul; 360(9328):196-202. PubMed ID: 12133653 [TBL] [Abstract][Full Text] [Related]
24. Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study. Çavuşoğlu Y; Korkmaz Ş; Demirtaş S; Gencer E; Şaşmaz H; Mutlu F; Güneş H; Mert UK; Özdemir S; Kalaycı S; Yılmaz MB Anatol J Cardiol; 2015 Aug; 15(8):611-7. PubMed ID: 26301344 [TBL] [Abstract][Full Text] [Related]
25. Correspondence concerning the article: is levosimendan better than dobutamine in acute heart failure in patients on beta blockade treatment? What is the evidence? Wikström BG Eur J Heart Fail; 2010 Aug; 12(8):893. PubMed ID: 20675671 [No Abstract] [Full Text] [Related]
26. Levosimendan use in several scenarios of acute heart failure. Tavares M; Andrade AC; Mebazaa A Arq Bras Cardiol; 2008 Mar; 90(3):211-5. PubMed ID: 18392402 [TBL] [Abstract][Full Text] [Related]
27. Inotropes and cardiorenal syndrome in acute heart failure - A retrospective comparative analysis. Madeira M; Caetano F; Almeida I; Fernandes A; Reis L; Costa M; Gonçalves L Rev Port Cardiol; 2017 Sep; 36(9):619-625. PubMed ID: 28826934 [TBL] [Abstract][Full Text] [Related]
28. The effects of levosimendan in cardiac surgery patients with poor left ventricular function. De Hert SG; Lorsomradee S; Cromheecke S; Van der Linden PJ Anesth Analg; 2007 Apr; 104(4):766-73. PubMed ID: 17377079 [TBL] [Abstract][Full Text] [Related]
29. Effect of levosimendan on E/E' ratio in patients with ischemic heart failure. Duygu H; Ozerkan F; Nalbantgil S; Zoghi M; Akilli A; Akin M; Nazli C; Ergene O Int J Cardiol; 2008 Jan; 123(2):201-3. PubMed ID: 17316845 [TBL] [Abstract][Full Text] [Related]
30. [Levosimendan treatment of severe acute congestive heart failure refractory to dobutamine/milrinone in children]. Prijić S; Rakić S; Nikolić L; Jovicić B; Stajević M; Vukomanović V; Kosutić J Vojnosanit Pregl; 2011 Nov; 68(11):979-84. PubMed ID: 22191317 [TBL] [Abstract][Full Text] [Related]
31. Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure. Nieminen MS; Akkila J; Hasenfuss G; Kleber FX; Lehtonen LA; Mitrovic V; Nyquist O; Remme WJ J Am Coll Cardiol; 2000 Nov; 36(6):1903-12. PubMed ID: 11092663 [TBL] [Abstract][Full Text] [Related]
32. Cardiogenic shock after primary percutaneous coronary intervention: Effects of levosimendan compared with dobutamine on haemodynamics. García-González MJ; Domínguez-Rodríguez A; Ferrer-Hita JJ; Abreu-González P; Muñoz MB Eur J Heart Fail; 2006 Nov; 8(7):723-8. PubMed ID: 16492404 [TBL] [Abstract][Full Text] [Related]
33. Levosimendan: a retrospective single-center case series. Berry WT; Hewson RW; Langrish CJ; McKenzie CA; Barrett NA J Crit Care; 2013 Dec; 28(6):1075-8. PubMed ID: 23998721 [TBL] [Abstract][Full Text] [Related]
34. Utility of the neutrophil to lymphocyte ratio for predicting in-hospital mortality after levosimendan infusion in patients with acute decompensated heart failure. Tasal A; Erturk M; Uyarel H; Karakurt H; Bacaksiz A; Vatankulu MA; Turfan M; Sonmez O; Erdogan E; Ergelen M J Cardiol; 2014 Jun; 63(6):418-23. PubMed ID: 24268422 [TBL] [Abstract][Full Text] [Related]
35. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN). Moiseyev VS; Põder P; Andrejevs N; Ruda MY; Golikov AP; Lazebnik LB; Kobalava ZD; Lehtonen LA; Laine T; Nieminen MS; Lie KI; Eur Heart J; 2002 Sep; 23(18):1422-32. PubMed ID: 12208222 [TBL] [Abstract][Full Text] [Related]
36. Can we believe in levosimendan? Follath F Arq Bras Cardiol; 2008 Mar; 90(3):146-7. PubMed ID: 18392391 [No Abstract] [Full Text] [Related]
37. Efficacy and safety of intermittent, long-term, concomitant dobutamine and levosimendan infusions in severe heart failure refractory to dobutamine alone. Nanas JN; Papazoglou P; Tsagalou EP; Ntalianis A; Tsolakis E; Terrovitis JV; Kanakakis J; Nanas SN; Alexopoulos GP; Anastasiou-Nana MI Am J Cardiol; 2005 Mar; 95(6):768-71. PubMed ID: 15757608 [TBL] [Abstract][Full Text] [Related]
38. Levosimendan compared with dobutamine in low output patients. Nieminen MS Minerva Anestesiol; 2003 Apr; 69(4):258-63. PubMed ID: 12766717 [TBL] [Abstract][Full Text] [Related]
39. [Hemodynamic and efficacies of domestic levosimendan versus dobutamine in patients with acute decompensated heart failure]. Zhang YH; Qing EM; Zhang J; Huang Y; Lü R; Zhou Q; Wei BQ; An T; Qing P; Zou CH Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(8):555-8. PubMed ID: 22490161 [TBL] [Abstract][Full Text] [Related]
40. Levosimendan: a review of its use in the management of acute decompensated heart failure. Innes CA; Wagstaff AJ Drugs; 2003; 63(23):2651-71. PubMed ID: 14636085 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]